G

Gossamer Bio

164 employees

Gossamer Bio is a San Diego-based clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension. Our goal is to enhance the lives of people living with pulmonary hypertension.

Investor insights

Funding rounds participated in

$212M sweet spot round size

Investor type

Public Company

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2017

Funding rounds raised

Total raised

$212M

from investors over 1 rounds

G

Gossamer Bio raised $212M on August 20, 2023